Professor X actor Christopher Abbott said Marvel fans won’t see him in Avengers: Doomsday or Secret Wars because he needs to wrap up his time […]
Author:
Elon Musk’s Grok Finally Delivers First Installment of ‘The Odyssey’
X boss shares first seven minutes of response to Christopher Nolan’s box office-dominating, critically acclaimed epic Three months after Elon Musk promised to make a […]
Forvia and Great Wall Motor expand partnership globally
Great Wall Motor’s agreement with Forvia shows Chinese automakers leaning on established suppliers as they localise abroad Forvia and Great Wall Motor have turned a […]
New Winter Storm Forecast for 11 States Warns of Snow This Week
Fall is in full swing, but winter may be making an early appearance in parts of the country. According to weather experts, this is the […]
La Tresse sur France 2 : le film qui a réuni 1,3 million de spectateurs il y a 3 ans est-il tiré d’une histoire vraie ? – Actus Ciné
La Tresse, le film mis en scène par Laetitia Colombani et diffusé sur France 2, est-il un récit totalement fictif ou est-il basé sur une […]
392 – New Show “Feeling Insecure? with Tim Nash”. Episode 1.
Tim Nash, seasoned WordPress security expert, launches “Feeling insecure?” podcast discussing tools, legislation, vulnerabilities, and security best practices for WordPress. This show, just like the […]
Two musings on the design of compiler warnings – Arthur O’Dwyer – Stuff mostly about C++
Today I finally write down some musings on two peripheral aspects of compiler diagnostic design that I think are very important for certain kinds of […]
Don’t Throw Away Your Old, Unsupported Nest Gadgets — Do This Instead
Google recently dropped support for some of its early smart thermostats. Choreograph (konstantin Yuganov)/Getty Images Google generated a bit of fury in October […]
Hermes Birkin bags built their reputation on rarity, but shifting resale demand is changing the conversation
For years, owning a Hermes Birkin bag was about more than carrying an expensive handbag. Its limited availability made it a status symbol, while the […]
A Win for Durvalumab Doublet in Muscle-Invasive Bladder Cancer
Perioperative treatment with durvalumab (Imfinzi) plus neoadjuvant enfortumab vedotin (EV) significantly improved event-free survival (EFS) and overall survival (OS) compared with radical cystectomy in patients […]